help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2004-1111
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wakida, N.
Right arrow Articles by Kitamura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wakida, N.
Right arrow Articles by Kitamura, K.
Related Collections
Right arrow Calcium and Bone Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 4 2169-2174
Copyright © 2005 by The Endocrine Society

Mutations in Human Urate Transporter 1 Gene in Presecretory Reabsorption Defect Type of Familial Renal Hypouricemia

Naoki Wakida1, Do Gia Tuyen1, Masataka Adachi, Taku Miyoshi, Hiroshi Nonoguchi, Toshiaki Oka, Osamu Ueda, Masahiro Tazawa, Satoshi Kurihara, Yoshitaka Yoneta, Hajime Shimada, Takashi Oda, Yuichi Kikuchi, Hirotaka Matsuo, Makoto Hosoyamada, Hitoshi Endou, Masaki Otagiri, Kimio Tomita and Kenichiro Kitamura

Departments of Nephrology (N.W., D.G.T., M.A., T.M., H.N., K.T., K.K.) and Biopharmaceutics (N.W., M.O.), Kumamoto University Graduate School of Medical and Pharmaceutical Sciences, Kumamoto 860-8556, Japan; Department of Pediatrics, Sapporo Tokushukai Hospital (T.Ok., O.U.), Hokkaido 003-0021, Japan; Department of Pediatrics, Fujita Health University School of Medicine (M.T.), Aichi 470-1192, Japan; Department of Medicine, Kasukabe Shuwa Hospital (S.K.), Saitama 344-0038, Japan; Department of Medicine, Kitasato Medical Center Hospital (Y.Y., H.S.), Saitama 364-0026, Japan; Second Department of Internal Medicine (T.Od., Y.K.) and First Department of Physiology (H.M.), National Defense Medical College, Saitama 359-0042, Japan; and Department of Pharmacology and Toxicology, Kyorin University School of Medicine (M.H., H.E.), Tokyo 181-8611, Japan

Address all correspondence and requests for reprints to: Dr. Kenichiro Kitamura, Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Kumamoto, Kumamoto 860-8556, Japan. E-mail: ken{at}gpo.kumamoto-u.ac.jp.

To date, 11 loss of function mutations in the human urate transporter 1 (hURAT1) gene have been identified in subjects with idiopathic renal hypouricemia. In the present studies we investigated the clinical features and the mutations in the hURAT1 gene in seven families with presecretory reabsorption defect-type renal hypouricemia and in one family with the postsecretory reabsorption defect type. Twelve affected subjects and 26 family members were investigated. Mutations were analyzed by PCR and the direct sequencing method. Urate-transporting activities of wild-type and mutant hURAT1 were determined by [14C]urate uptake in Xenopus oocytes. Mutational analysis revealed three previously reported mutations (G774A, A1145T, and 1639–1643 del-GTCCT) and a novel mutation (T1253G) in families with the presecretory reabsorption defect type. Neither mutations in the coding region of hURAT1 gene nor significant segregation patterns of the hURAT1 locus were detected in the postsecretory reabsorption defect type. All hURAT1 mutants had significantly reduced urate-transporting activities compared with wild type (P < 0.05; n = 12), suggesting that T1253G is a loss of function mutation, and hURAT1 is responsible for the presecretory reabsorption defect-type familial renal hypouricemia. Future studies are needed to identify a responsible gene for the postsecretory reabsorption defect-type familial renal hypouricemia.




This article has been cited by other articles:


Home page
IBMS BoneKEyHome page
D. Prie and G. Friedlander
Genetic Causes of Renal Lithiasis
IBMS BoneKEy, October 1, 2009; 6(10): 357 - 367.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Anzai, K. Ichida, P. Jutabha, T. Kimura, E. Babu, C. J. Jin, S. Srivastava, K. Kitamura, I. Hisatome, H. Endou, et al.
Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans
J. Biol. Chem., October 3, 2008; 283(40): 26834 - 26838.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Hagos, D. Stein, B. Ugele, G. Burckhardt, and A. Bahn
Human Renal Organic Anion Transporter 4 Operates as an Asymmetric Urate Transporter
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 430 - 439.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

The relation between renal hypouricemic subtype and genotype based on pharmacological loading tests.
Kimiyoshi Ichida, et al.
JCEM Online, 15 Aug 2006 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society